ScreenerHero
IDHCIntegrated Diagnostics Holdings plc
LSE · GB · Healthcare · Diagnostics & Research · idhcorp.com
0.5220USD+2.35%Mkt Cap: 296.48M $P/E: 10.20

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematolo…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.64BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMerieux S.A.
$9.51BUSDP/E 19.0
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8
TWST
Twist Bioscience Corp.
$8.93BUSD

Key Statistics

Company
Market Cap296.48M $
Enterprise Value—
Revenue (TTM)—
Gross Profit3.35B $
Net Income (TTM)1.26B $
Revenue/Share—
Last Price0.5220 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7.1K
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISINJE00BLKGSR75
Valuation
P/E (Trailing)10.20
P/E (Forward)0.29
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.10
EPS (TTM)0.05
EPS (Forward)1.77
52W Range
0.510027% of range0.5540
52W High0.5540 USD
52W Low0.5100 USD
Profitability
Gross Margin42.69%
Oper. Margin0.00%
EBITDA Margin30.86%
Profit Margin16.07%
ROE37.31%
ROA14.69%
Growth
Revenue Growth31.00%
Earnings Growth78.40%
Cash Flow & Leverage
Operating CF1.90B $
CapEx (TTM)521.04M $
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.48
Current Ratio—
Quick Ratio—
Book Value/Sh5.373 USD
Cash/Share—
Dividends
Fwd Div Rate0.0100 USD
Trail. Div Rate0.0000 USD
Div. Yield1.63%
5Y Avg Yield—
Payout Ratio32.68%
Ex-Div DateMay 28, 2026
Pay Date—
Splits
Last Split4:1
Split DateDec 24, 2020
Analyst Consensus
Rating—
Target (Mean)0.8506 USD
Upside (mean)+63.0%
Target Range0.7405 USD – 0.9608 USD
$0.7405+63.0% to mean$0.9608
# Analysts2
Ownership
Shares Out.581.33M
Float124.85M
Insiders58.73%
Institutions45.00%
Technical
SMA 500.5342 (-2.3%)
SMA 2000.6037 (-13.5%)
Beta0.40
S&P 52W Chg20.80%
Avg Vol (30d)32.19K
Avg Vol (10d)204.48K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—